Maintaining Safety with SARS-CoV-2 Vaccines

Viewpoint article comments on the expedited recent approval of these vaccines and reports of anaphylaxis with the Pfizer vaccine and concludes careful vaccine-safety surveillance over time will be needed to inform a strategic and systematic approach to vaccine safety.

New England Journal of Medicine